Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 4Classical hematology 4Myeloid 3Plasma cell 2Lymphoid 2Genitourinary 1

Conditions

Multiple Myeloma 13Leukemia, Lymphocytic, Chronic, B-Cell 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Hodgkin Disease 11Lymphoma, Mantle-Cell 10Leukemia, Myeloid, Acute 10Waldenstrom Macroglobulinemia 8Lymphoma, Non-Hodgkin 8Lymphoma, Large B-Cell, Diffuse 8Leukemia, Myeloid, Chronic-Phase 7Myelodysplastic-Myeloproliferative Diseases 6Myelodysplastic Syndromes 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Prolymphocytic 5Myeloproliferative Disorders 4Burkitt Lymphoma 4Primary Myelofibrosis 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myeloid, Accelerated Phase 3Hematologic Neoplasms 3Graft vs Host Disease 3Congenital Abnormalities 3Sezary Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Neoplasms, Plasma Cell 2

Interventions

Cyclophosphamide 16fludarabine phosphate 15Mycophenolic Acid 14Cyclosporine 13Peripheral Blood Stem Cell Transplantation 9Whole-Body Irradiation 8Cord Blood Stem Cell Transplantation 8Busulfan 7Antilymphocyte Serum 7Radiotherapy 5Tacrolimus 4Methylprednisolone 4fludarabine 3Methotrexate 3Granulocyte Colony-Stimulating Factor 2Filgrastim 2Etoposide 2Cytarabine 2Cyclosporins 2sargramostim 1Transplantation 1Thiotepa 1Tetradecanoylphorbol Acetate 1Melphalan 1Leucovorin 1Immunologic Techniques 1Hematopoietic Stem Cell Transplantation 1Enzyme-Linked Immunosorbent Assay 1Deferasirox 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anemia, Refractory × Cyclosporins × Plasma cell × Clear all
NCT00719888 2025-03-07

Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease

Fred Hutchinson Cancer Center

Phase 2 Completed
135 enrolled 19 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT00027820 2019-12-20

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

Fred Hutchinson Cancer Center

Phase 1/2 Completed
106 enrolled
Classical hematologyGenitourinaryLymphoidOther hematologic neoplasmPlasma cell

Anemia, Refractory, Carcinoma, Renal Cell, Hodgkin Disease, Leukemia, Plasma Cell, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡